Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.48
+0.92 (3.60%)
Oct 6, 2025, 1:35 PM EDT - Market open
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.45 billion as of October 6, 2025. Its market cap has increased by 81.09% in one year.
Market Cap
1.45B
Enterprise Value
1.05B
1-Year Change
81.09%
Ranking
Category
Stock Price
$26.48
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.45B, an increase of 80.37%. That is a compound annual growth rate of 9.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 1.40B | 139.74% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |